Get the Stockscreener App
135.79
0.53%
-0.72
Davita Inc stock is traded at $135.79, with a volume of 833.55K.
It is down -0.53% in the last 24 hours and down -6.62% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$136.51
Open:
$136.27
24h Volume:
833.55K
Relative Volume:
1.04
Market Cap:
$10.51B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
12.64
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-1.72%
1M Performance:
-6.62%
6M Performance:
-7.47%
1Y Performance:
-4.51%
1-Day Range:
$135.25
$138.26
1-Week Range:
$134.64
$138.29
52-Week Range:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
135.79 | 10.51B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
376.86 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.94 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
167.58 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
119.75 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
171.24 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - ACCESS Newswire
Bernstein Adjusts Price Target on DaVita to $150 From $184, Maintains Market Perform Rating - MarketScreener
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Allen learns about dialysis legislation - Statesboro Herald
DaVita to offer $750M of senior notes in private offering - MSN
DaVita Inc. (NYSE:DVA) Shares Sold by Two Sigma Investments LP - Defense World
Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - FinancialContent
Those who invested in DaVita (NYSE:DVA) five years ago are up 76% - simplywall.st
DaVita HealthCare (DVA) Down 3.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
DaVita Inc. (DVA) Announces Results of 2025 Annual Meeting of St - GuruFocus
DaVita Holds 2025 Annual Stockholders Meeting - TipRanks
Wellington Management Group LLP Raises Position in DaVita Inc. (NYSE:DVA) - Defense World
DaVita (DVA): Company Profile, Stock Price, News, Rankings - Fortune
DaVita (DVA) Welcomes Extended Kidney Care Choices Model | DVA S - GuruFocus
DaVita commends extension of Kidney Care Choices Model By Investing.com - Investing.com South Africa
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News - GuruFocus
DaVita (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News - GuruFocus
DaVita commends extension of Kidney Care Choices Model - Investing.com
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
DaVita Inc. (NYSE:DVA) Given Average Recommendation of “Hold” by Brokerages - Defense World
Berkshire Hathaway sells $27.8 million in DaVita shares By Investing.com - Investing.com South Africa
Berkshire Hathaway sells $27.8 million in DaVita shares - Investing.com
DaVita: International Expansion And Buybacks Will Boost Returns (NYSE:DVA) - Seeking Alpha
DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.96% Potential Upside in the Dialysis Market - DirectorsTalk Interviews
Ameriprise Financial Inc. Grows Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
DaVita’s SWOT analysis: healthcare giant faces treatment growth hurdles - Investing.com Australia
DaVita’s SWOT analysis: healthcare giant faces treatment growth hurdles By Investing.com - Investing.com Nigeria
DaVita Completes $1 Billion Senior Notes Offering - TipRanks
DaVita Inc. (DVA) Announces $750 Million Senior Notes Offering - GuruFocus
DaVita Outshines Wall Street With First-Quarter Profit Beat - Finimize
DaVita upsizes senior notes offering to $1 billion By Investing.com - Investing.com South Africa
DaVita launches $750 million senior notes offering By Investing.com - Investing.com South Africa
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering - The Malaysian Reserve
DaVita (DVA) Announces Upsized $1 Billion Senior Notes Offering - GuruFocus
DaVita Upsizes Private Offering to $1 Billion - TipRanks
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior No - GuruFocus
DaVita upsizes senior notes offering to $1 billion - Investing.com
Davita Inc. Announces Upsize And Pricing Of $1 Billion Senior Notes Offering - marketscreener.com
DaVita Inc. Announces Offering of $750 Million Senior Notes - marketscreener.com
DaVita Begins Private Offering Of $750 Mln Of Senior Notes - Nasdaq
DaVita Announces $750M Senior Notes Offering - TipRanks
DaVita Launches $750 Million Senior Note Offering - marketscreener.com
DaVita launches $750 million senior notes offering - Investing.com Australia
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship | DVA Stock News - GuruFocus
DaVita Inc. Announces Offering of $750 Million Senior Notes | DVA Stock News - GuruFocus
DaVita (DVA) Stock Holds Steady as Truist Securities Lowers Pric - GuruFocus
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC | 10% Owner |
May 23 '25 |
Sale |
137.81 |
64,066 |
8,828,933 |
33,899,815 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
May 22 '25 |
Sale |
138.98 |
32,660 |
4,538,983 |
33,963,881 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
May 08 '25 |
Sale |
147.11 |
1,145,938 |
168,576,647 |
33,996,541 |
| HEARTY JAMES O | Chief Compliance Officer |
Mar 03 '25 |
Option Exercise |
75.95 |
4,609 |
350,054 |
28,669 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Feb 14 '25 |
Sale |
154.94 |
500,000 |
77,471,996 |
35,392,479 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Feb 19 '25 |
Sale |
154.09 |
129,938 |
20,022,517 |
35,142,479 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Feb 18 '25 |
Sale |
154.60 |
120,062 |
18,561,103 |
35,272,417 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Feb 11 '25 |
Sale |
156.01 |
203,091 |
31,684,430 |
35,892,479 |
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Nov 27 '24 |
Option Exercise |
108.93 |
8,078 |
879,937 |
97,706 |
0.30%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):